Japan's Ono Pharma slumps as Merck drug succeeds lung cancer trial

ONO PHARMACEUTICAL

10/04/2018 05:39

** Shares of Ono Pharmaceutical Co Ltd  4528.T , which makes
cancer drug Opdivo, plunge 15 pct to more than 2-month low of
2,852.5 yen as rival drugmaker's success weighs  
    ** Drugmaker Merck & Co Inc's  MRK.N  blockbuster drug
succeeds pivotal lung cancer trial  urn:newsml:reuters.com:*:nL3N1RM3VO
    ** MRK says late-stage study of its drug Keytruda met main
goal of helping previously untreated lung cancer patients live
longer 
    ** As of last close, Ono Pharma stock had risen 28.5 pct
this year
    ** About 10.76 mln shares have been traded as of 0430 GMT, 
compared with their 30-day moving average of 2.45 mln shares a
day

 ((Reuters
Messaging:ayai.tomisawa.thomsonreuters.com@reuters.net))